SNY - French Drugmaker Sanofi Secures European Medicines Agency's Positive Opinion For Sleeping Sickness Treatment | Benzinga
Sanofi SA (NASDAQ: SNY), DNDi, and the HAT-r-ACC consortium announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole Winthrop as a first oral treatment of an acute form of sleeping sickness (rhodesiense).
This positive opinion is for the treatment in adults and children six years of age or older and weighing at least 20 kg of both first-stage (haemo-lymphatic) ...